+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sickle Cell Anemia Testing and Screening Market Outlook 2026-2034: Market Size, Share and Growth Analysis- Product Image
Sickle Cell Anemia Testing and Screening Market Outlook 2026-2034: Market Size, Share and Growth Analysis- Product Image
Sale

Sickle Cell Anemia Testing and Screening Market Outlook 2026-2034: Market Size, Share and Growth Analysis

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6243562
UP TO OFF until Jan 01st 2027
Description Jump to:
The Sickle Cell Anemia Testing and Screening Market is estimated at US$609.1 million in 2026 and is projected to grow at a CAGR of 13.1% to reach US$1.63 billion by 2034.

Market Overview

The Sickle Cell Anemia Testing and Screening Market covers diagnostic services, laboratory tools, and screening programs used to detect sickle cell disorders and carrier status across newborn, prenatal, and population health settings. Its value chain includes reagent suppliers, diagnostics manufacturers, laboratories, hospitals, public health agencies, screening program administrators, and patient care providers.

Core applications include newborn screening, prenatal testing, carrier detection, hospital diagnostics, public health surveillance, and community health programs. At the same time, suppliers must respond to laboratory access disparities, reimbursement complexity, follow up care coordination, and limited awareness in under screened populations.

Key Companies Analysed

  • Bio-Rad Laboratories
  • PerkinElmer
  • Revvity
  • Abbott
  • Danaher
  • Siemens Healthineers
  • Roche
  • Thermo Fisher Scientific
  • Bio-Techne
  • Hologic
  • Sysmex
  • Beckman Coulter
  • Agilent Technologies
  • Cepheid
  • Illumina
  • Becton Dickinson
  • EKF Diagnostics
  • Randox
  • Trivitron Healthcare
  • NeoGenomics

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Sickle Cell Anemia Testing and Screening Market Overview
2.1. Sickle Cell Anemia Testing and Screening Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Sickle Cell Anemia Testing and Screening Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Sickle Cell Anemia Testing and Screening Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Sickle Cell Anemia Testing and Screening Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ million)
6. North America Sickle Cell Anemia Testing and Screening Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Outlook By Country
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
7. Europe Sickle Cell Anemia Testing and Screening Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Outlook By Country
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Poland
7.2.9. Sweden
7.2.10. Russia
8. Asia-Pacific Sickle Cell Anemia Testing and Screening Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Outlook By Country
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Malaysia
8.2.8. Vietnam
9. Middle East and Africa Sickle Cell Anemia Testing and Screening Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Outlook By Country
9.2.1. Saudi Arabia
9.2.2. South Africa
9.2.3. Iran
9.2.4. United Arab Emirates
9.2.5. Egypt
10. South and Central America Sickle Cell Anemia Testing and Screening Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Outlook By Country
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Chile
10.2.4. Peru
11. Sickle Cell Anemia Testing and Screening Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Bio-Rad Laboratories
11.2.2. PerkinElmer
11.2.3. Revvity
11.2.4. Abbott
11.2.5. Danaher
11.2.6. Siemens Healthineers
11.2.7. Roche
11.2.8. Thermo Fisher Scientific
11.2.9. Bio-Techne
11.2.10. Hologic
11.2.11. Sysmex
11.2.12. Beckman Coulter
11.2.13. Agilent Technologies
11.2.14. Cepheid
11.2.15. Illumina
11.2.16. Becton Dickinson
11.2.17. EKF Diagnostics
11.2.18. Randox
11.2.19. Trivitron Healthcare
11.2.20. NeoGenomics
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Bio-Rad Laboratories
  • PerkinElmer
  • Revvity
  • Abbott
  • Danaher
  • Siemens Healthineers
  • Roche
  • Thermo Fisher Scientific
  • Bio-Techne
  • Hologic
  • Sysmex
  • Beckman Coulter
  • Agilent Technologies
  • Cepheid
  • Illumina
  • Becton Dickinson
  • EKF Diagnostics
  • Randox
  • Trivitron Healthcare
  • NeoGenomics

Table Information

Report AttributeDetails
No. of Pages160
PublishedOctober 2026
Forecast Period2026 - 2034
Estimated Market Value ( USD ) in 2026 $ 609.1 Million
Forecasted Market Value ( USD ) by 2034 $ 1630.8 Million
Compound Annual Growth Rate13.1%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Rapid Point-of-Care Testing for Sickle Cell Anemia Market Size, Share & Trends Analysis Report by Type, Technology, Age Group, Sector Type, Distribution Channel, End-use, and Region, and Segment Forecast, 2026-2033 - Product Image

Rapid Point-of-Care Testing for Sickle Cell Anemia Market Size, Share & Trends Analysis Report by Type, Technology, Age Group, Sector Type, Distribution Channel, End-use, and Region, and Segment Forecast, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Sickle Cell Anemia Testing & Screening Market - Global Forecast 2026-2032 - Product Image

Sickle Cell Anemia Testing & Screening Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Sickle Cell Anemia Testing and Screening - Global Strategic Business Report - Product Image

Sickle Cell Anemia Testing and Screening - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Anemia Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Anemia Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Anemia Treatment Market Outlook 2026-2034: by Disease Type (Iron Deficiency Anemia, CKD Anemia, Sickle Cell Anemia, Aplastic Anemia, Thalassemia, Other Rare Anemias), Route of Administration, Therapy Class - Product Image

Anemia Treatment Market Outlook 2026-2034: by Disease Type (Iron Deficiency Anemia, CKD Anemia, Sickle Cell Anemia, Aplastic Anemia, Thalassemia, Other Rare Anemias), Route of Administration, Therapy Class

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.